Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Irbesartan and Hydrochlorothiazide Capsules

Approval Number

国药准字H20060811

Company元和药业股份有限公司

Registration Date

December 15, 2020

Previous Approval Numbers

国药准字H20060811

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪胶囊

Trade Name

安利博

Brand Name

安利博

Dosage Form

胶囊剂

Strength

每粒含厄贝沙坦150mg,氢氯噻嗪12.5mg。

Drug Type

化学药品

Registration Date

December 15, 2020

Company Information

Applicant Company

Company Name元和药业股份有限公司

Company Address

内蒙古自治区呼和浩特经济技术开发区金川区金二道

Manufacturing Company

Company Name元和药业股份有限公司

Company Address

内蒙古自治区呼和浩特经济技术开发区金川区金二道

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy